20
Alkem Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ARIPIPRAZOLE USP, with a corresponding US DMF Number 27909.
Remarkably, this DMF maintains an Active status since its submission on February 13, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on April 21, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II